Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Nicolaus Kröger,Hermann Einsele,Daniel Wolff,Jochen Casper,Mathias Freund,Günter Derigs,Hannes Wandt,Kerstin Schäfer-Eckart,Georg Wittkowsky,Norbert Schmitz,William Krüger,Tatjana Zabelina,Helmut Renges,Francis Ayuk,Andreas Krüll,Axel R. Zander

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

2003

Nicolaus Kröger
Hermann Einsele
Daniel Wolff
Jochen Casper
Mathias Freund
Günter Derigs
Hannes Wandt
Kerstin Schäfer-Eckart
Georg Wittkowsky
Norbert Schmitz
William Krüger
Tatjana Zabelina
Helmut Renges
Francis Ayuk
Andreas Krüll
Axel R. Zander

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

Keywords:

Regimen
Total body irradiation
Transplantation Conditioning
Immunology
Busulfan
Progression-free survival
Anti-thymocyte globulin
Medicine
Multiple myeloma
Cyclophosphamide
conditioning regimen
In vivo
Survival rate
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations